Lobster hemolymph as a utility for treatment of mammalian tissue lesions
US9078906B2 · kind B2 · utility
1Cited by
1References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 16, 2013 |
| Grant date | Jul 14, 2015 |
| Priority date | — |
| Expiry date | Feb 16, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is crustacean hemolymph as a utility for the pharmaceutical and/or cosmetic treatment of viral and other neoplastic or pre-neoplastic mammalian tissue lesions. The method comprises topically administering to mammalian tissue a formula that is made from lobster hemolymph—neat; or lobster hemolymph extracts; or lobster hemolymph in combination with certain carriers, binders; or as an adjuvant. The hemolymph may be from various species of lobster, Homarus americanus in particular.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.